Estimated Comparative Costs of Achieving a 20% Reduction in Intraocular Pressure with Bimatoprost or Latanoprost in Patients with Glaucoma or Ocular Hypertension

Author： Fiscella Richard  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.23, Iss.1, 2006-01, pp. : 39-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In patients with ocular hypertension or open angle glaucoma, lowering intraocular pressure reduces the risk of visual field loss

By  

Inpharma, Vol. 1, Iss. 1496, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Latanoprost: An Update of its Use in Glaucoma and Ocular Hypertension

By Perry C.M.   McGavin J.K.   Culy C.R.   Ibbotson T.  

Drugs & Aging, Vol. 20, Iss. 8, 2003-01 ,pp. : 597-630

Adis International

Access to resources Recommend Favorite

Topical Bimatoprost: A Review of its Use in Open-Angle Glaucoma and Ocular Hypertension

By Easthope S.E.   Perry C.M.  

Drugs & Aging, Vol. 19, Iss. 3, 2002-01 ,pp. : 231-248

Adis International

Access to resources Recommend Favorite

Bimatoprost: A Pharmacoeconomic Review of its Use in Open-Angle Glaucoma and Ocular Hypertension

By Plosker Greg L.   Keam Susan J.  

PharmacoEconomics, Vol. 24, Iss. 3, 2006-01 ,pp. : 297-314

Adis International

Access to resources Recommend Favorite

Bimatoprost: A Review of its Use in Open-Angle Glaucoma and Ocular Hypertension

By Curran Monique P.  

Drugs & Aging, Vol. 26, Iss. 12, 2009-12 ,pp. : 1049-1071

Adis International

Access to resources Recommend Favorite